We are live on ! Find out more
OLMA icon

Olema Pharmaceuticals
OLMA

97 hedge funds and large institutions have $359M invested in Olema Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 41 funds opening new positions, 33 increasing their positions, 13 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

408% more call options, than puts

Call options by funds: $1.16M | Put options by funds: $229K

154% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 13

116% more first-time investments, than exits

New positions opened: 41 | Existing positions closed: 19

28% more funds holding

Funds holding: 76 → 97 (+21)

2.5% more ownership

Funds ownership: 92.88% → 95.38% (+2.5%)

65% less capital invested

Capital invested by funds: $1.01B → $359M (-$653M)

100% less funds holding in top 10

Funds holding in top 10: 5 → 0 (-5)

Holders
97
Holders Change
+21
Holders Change %
+27.63%
% of All Funds
1.49%
Holding in Top 10
–
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-100%
% of All Funds
–
New
41
Increased
33
Reduced
13
Closed
19
Calls
$1.16M
Puts
$229K
Net Calls
+$935K
Net Calls Change
+$389K

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$15.5M
2
Two Sigma Advisers
Two Sigma Advisers
New York
+$11.6M
3
Two Sigma Investments
Two Sigma Investments
New York
+$10.9M
4
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$10.8M
5
Morgan Stanley
Morgan Stanley
New York
+$10.5M

Top Sellers

Rank Fund Capital Flow
1
O
OrbiMed
New York
-$22.3M
2
CAM
Cormorant Asset Management
Massachusetts
-$18.7M
3
VA
VR Adviser
New York
-$14.9M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$12.3M
5
FCMI
Foresite Capital Management IV
California
-$9.43M
Name Holding Trade Value Shares
Change 		Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$2.35M +$100K +4,843 +2%
Millennium Management
27
Millennium Management
New York
$2.32M +$5.15M +248,328 New
OCA
28
Octagon Capital Advisors
New York
$2.17M +$4.79M +231,417 New
Goldman Sachs
29
Goldman Sachs
New York
$2.04M +$1.39M +66,981 +44%
Voloridge Investment Management
30
Voloridge Investment Management
Florida
$2.02M +$4.47M +215,857 New
Charles Schwab
31
Charles Schwab
California
$1.9M +$136K +6,586 +3%
Walleye Capital
32
Walleye Capital
New York
$1.78M +$3.95M +190,523 New
Royal Bank of Canada
33
Royal Bank of Canada
Ontario, Canada
$1.12M +$2.43M +117,098 +4,523%
Bank of America
34
Bank of America
North Carolina
$1.08M +$1.86M +89,864 +355%
Deutsche Bank
35
Deutsche Bank
Germany
$1M +$20.3K +980 +0.9%
Acadian Asset Management
36
Acadian Asset Management
Massachusetts
$940K +$2.08M +100,622 New
HF
37
HRT Financial
New York
$905K +$2.01M +96,789 New
PVI
38
Pura Vida Investments
New York
$874K +$1.93M +93,330 New
Bank of New York Mellon
39
Bank of New York Mellon
New York
$828K +$140K +6,781 +8%
D.E. Shaw & Co
40
D.E. Shaw & Co
New York
$824K +$428K +20,656 +31%
CSS
41
Cubist Systematic Strategies
Connecticut
$797K +$899K +43,366 +104%
OQS
42
Occudo Quantitative Strategies
Florida
$723K +$1.6M +77,203 New
Marshall Wace
43
Marshall Wace
United Kingdom
$721K +$653K +31,514 +69%
T. Rowe Price Associates
44
T. Rowe Price Associates
Maryland
$657K +$1.45M +70,172 New
Nomura Holdings
45
Nomura Holdings
Japan
$582K +$1.29M +62,153 New
HS
46
HighVista Strategies
Massachusetts
$477K +$620K +29,943 +143%
EWA
47
EP Wealth Advisors
California
$433K +$958K +46,248 New
Walleye Trading
48
Walleye Trading
New York
$386K +$855K +41,260 New
GCP
49
GSA Capital Partners
United Kingdom
$377K +$833K +40,227 New
PPA
50
Parametric Portfolio Associates
Washington
$368K +$242K +11,675 +42%
1
2
3 4 5

OLMA Hedge Fund Activity: Q4 2021 in Review

97 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Olema Pharmaceuticals (OLMA) for Q4 2021, worth a combined $359M — down 65% from $1.01B a quarter earlier.

Buyers outnumbered sellers: 41 funds opened new OLMA positions and 19 closed out — a net gain of 22 holders — while 33 added to existing stakes and 13 trimmed.

The largest buyer was BVF Inc, adding an estimated $15.5M. The largest seller was OrbiMed, exiting entirely with an estimated $22.3M sold.

  • 97 institutional investors held Olema Pharmaceuticals (OLMA) as of Q4 2021, up from 76 in Q3 2021.
  • Funds reported $359M of Olema Pharmaceuticals stock for Q4 2021, down 65% quarter-over-quarter.
  • 41 funds opened new Olema Pharmaceuticals positions in Q4 2021 and 19 closed out, a net change of +22 holders.
  • The largest Olema Pharmaceuticals buyer in Q4 2021 was BVF Inc, an estimated $15.5M added.
  • The largest Olema Pharmaceuticals seller in Q4 2021 was OrbiMed, an estimated $22.3M sold.

Based on aggregated 13F filings for Q4 2021.